TransMedics Group Non-GAAP EPS of $0.44 misses by $0.04, revenue of $189.9M beats by $5.91M (TMDX:NASDAQ)
· seekingalpha.com
TransMedics (TMDX) Q2 results: Non-GAAP EPS miss, revenue beat, and 2026 revenue guidance raised.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...